岩井化学/MC-210支原体去除剂（MRA）/细胞培养/KM881012
市场价：
¥0.00
美元价：
0.00
产品分类：
信号通路
公司分类：
Signal_pathway
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
Product Description
KAC’s MC-210 Mycoplasma Removal Agent (MRA) contains quinoline as an antibiotic due to its mycoplasmacidal properties. Quinoline inhibits mycoplasma DNA gyrase or the topoisomerase IV enzyme and interferes with DNA replication. Recommended treatment dose is 0.5 μg/mL for 1 week. Developed by Dainippon Pharmaceuticals, it has proven to be an effective elimination treatment with low cell toxicity for over 20 years.
MC-210is a cost-effective solution for eliminating mycoplasma contamination. This agent demonstrates high removal effects against common contaminants such asmycoplasma orale.
Mycoplasma contamination can alter an endless number of parameters in unpredictable ways. Mycoplasma often cohabits with your cells instead of killing your cultures and it skews titers before producing noticeable effects. It can interfere withcell migration, signal transduction, lymphocyte activation, and cytokine expression.
Characteristics:
- Exerts potent antimycoplasma effects for a diverse range of mycoplasma.
- Demonstrated mycoplasmacidal activity. Accordingly, once mycoplasma is removed from cultured cells, mycoplasma does not grow again.
- Simple to use - To remove contamination, just add this agent and culture for about one week.
Size: 5mL
Concentration: 50 µg/mL
Storage method:
Stable at room temperature (4°C - 37°C). Please protect from light and store in the dark.
Instructions for Use:
1. Add the agent at a final concentration of 0.5µg/mL
to cultured cells contaminatedby mycoplasma
and wait for one week.
Example: With 10mL of culture media
in a 25cm² culture flask, add 0.1mL of agent.
2. When the culture media is changed,
add the agent at acomparable concentration.
3. After one week, add media without the agent
and verify that there is no mycoplasma
growth in the cell culture.
Precautions:
This agent is for research purposes and should be used only as a mycoplasmacidal agent for cell culture. Please strictly follow the required concentration for use (0.5µg/mL). If mycoplasma is still observed after treatment, increase the concentration to1µg/mL.
Toxicity of this agent to cultured cells is low, and cytotoxicity was not observed at the required concentration. However, for specific functions of cells, please verify that there are no abnormalities after mycoplasma removal.
Reference Data:
Documents:
Specifications (Coming Soon)
Material Safety Data Sheet(Coming Soon)
品牌介绍
Iwai-Chem岩井北美有限公司是岩井化学株式会社（位于日本）的美国全资子公司，成立于2006年，是岩井向国际市场扩张的一部分。致力于弥合美国和日本生命科学产业之间的鸿沟，北美洲岩井提供了从日本到美国市场的高质量试剂和研究工具，同时还向日本提供了美国技术和产品。 历史：* 1947年4月–岩井化学株式会社在日本东京成立 * 2006年10月–岩井北美有限公司在加利福尼亚州伯灵格姆成立。* 2007年9月–收购了Iwai USA Inc.及其所有资产， 包括Chondrex，Inc.的多数股权。 * 2009年2月–办公室迁至加利福尼亚福斯特城* 2017年4月－办公室搬迁至加利福尼亚州圣卡洛斯的当前地址 关于 岩井化学株式会社 （日本）： 岩井化学株式会社成立于1947年，位于日本东京，旨在生产和分配高纯度试剂。在过去的七十年中，岩井化学一直秉持“诚信”作为其管理理念的基石，并深知只有赢得客户的信任，企业才能继续创新和发展。自岩井创立以来，生命科学研究领域取得了显着进展，特别是在分子生物学，基因工程和免疫学领域。通过对这些研究领域中对专用试剂的需求进行预测并采取行动，并与国内外主要制造商建立合作伙伴关系，从而形成了一条完整的产品线，岩井化学已达到了目前的行业领导者地位。如今，岩井化学公司拥有70多名销售人员，为450多家制药公司，大学和研究机构的2500多个研究实验室提供服务，年销售额约为1.6亿美元，这使岩井化学公司占据了日本全部生物制品的10％试剂零售市场。
联络我们
